Oracle Corporation

New York Stock Exchange
Back to all articles
Bullish +75

Why Oppenheimer Says Oracle Stock Can Gain 25% from Here - Barchart

📈 Oppenheimer upgrades Oracle (ORCL) to 'Outperform' with a $185 price target, suggesting a 25% upside from current levels.

💰 Oracle reported $57 billion in revenue for fiscal 2025 and guides for $225 billion by 2030 (31% CAGR).

📊 Non-GAAP EPS is projected to double by 2030, reaching $21 with a 28% compound annual growth rate.

💸 Oracle raised a record $25 billion in debt in February 2026 and has a $40B-$50B financing program planned for 2026.

🛡️ The company holds a $19.2 billion cash buffer as of Q2 fiscal 2026, easing liquidity concerns.

📉 Stock price corrected 34% in the last six months and trades at a forward P/E of 24.18 times.

🤝 Oracle has secured commitments from major clients including OpenAI, Meta Platforms, and Nvidia.

📅 The company has $523 billion in remaining performance obligations (RPO) to recognize over the next five years.

🔍 Analyst consensus is 'Strong Buy' with a mean price target of $284.02 implying 91% upside.

🚀 OpenAI plans to spend approximately $600 billion on computing power by 2030, benefiting Oracle and Microsoft.

Bullish Signals
  • Oppenheimer upgraded the stock to 'Outperform' with a specific price target of $185.
  • Oracle's revenue is guided to grow at a 31% CAGR from fiscal 2025 to 2030.
  • The company has secured a record $25 billion debt raise and plans a massive $40B-$50B financing program for 2026.
  • Oracle holds a substantial $19.2 billion cash buffer, reducing execution risk.
  • Major clients like OpenAI, Meta, and Nvidia have committed to significant spending on Oracle's cloud infrastructure.
  • The stock has corrected significantly (34% in six months) while maintaining strong growth fundamentals.
  • Analyst consensus is overwhelmingly positive with a mean price target of $284.02.
  • Oracle offers an annual dividend yield of 1.38% alongside high growth potential.
Risk Factors
  • Market skepticism remains regarding the execution risk associated with Oracle's massive remaining performance obligations (RPO).
  • The stock has experienced a sharp downtrend and corrected by 34% in the last six months.
  • Investors are concerned about the impact of heavy AI investments on the balance sheet and cash flows.
Full Analysis
Oppenheimer has upgraded Oracle (ORCL) stock to an 'Outperform' rating from 'Perform', setting a price target of $185, which implies a potential 25% gain. The bullish thesis centers on the view that Oracle is poised to be a strong earnings per share (EPS) compounder. Despite market concerns regarding AI investment impacts on the balance sheet and cash flows, Oppenheimer argues these risks are overstated after discounting them. Oracle's financial outlook remains robust with ambitious growth targets. The company guided for revenue of $57 billion in fiscal 2025 and projects reaching $225 billion by 2030, implying a compound annual growth rate (CAGR) of 31%. Non-GAAP EPS is expected to grow at a CAGR of 28% to reach $21 by fiscal 2030. The stock currently trades at a forward P/E ratio of 24.18 times, which analysts consider attractive given the long-term growth potential. Financing and execution risks have been mitigated by recent capital market activities. Oracle announced a $40 billion to $50 billion equity and debt financing program for 2026 and successfully raised a record $25 billion in debt in February 2026. With a cash buffer of $19.2 billion as of Q2 fiscal 2026, the company is well-positioned to fund its growth initiatives without liquidity concerns.